Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Aquestive Therapeutics, Inc. (AQST) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Aquestive Therapeutics, Inc. (AQST), most recent 12 months reported: revenue $54.09M, net loss $78.23M, free cash flow -$45.95M. Latest balance sheet on file: liquid cash $98.49M. From SEC filings. Others in Pharmaceutical Preparations: Bicycle Therapeutics plc · AYTU BIOPHARMA, INC. · Nektar Therapeutics · PROTHENA CORPORATION PUBLIC LIMITED COMPANY · Tango Therapeutics, Inc. · Q32 Bio Inc. · Siga Technologies INC · GOSSAMER BIO, INC.

Stock screener

Watchlist